Latest
Developing News

White House Pulls Heidi Overton’s FDA Nomination Amid Senate Concerns

The physician and White House policy adviser faced bipartisan questions ahead of a scheduled committee vote.

Read the story
Developing News · Read the story
Conceptual torn-paper illustration of the U.S. Capitol and a health-policy document beside a headline about Heidi Overton’s FDA nomination.
Conceptual editorial illustration; not an image of the reported event
Share this story

Nomination pulled before committee vote

November 18, 2026, 01:51 UTC.

The White House has pulled Dr. Heidi Overton’s nomination to lead the Food and Drug Administration, the Associated Press reported, citing the White House.

The decision followed growing indications that Overton, a physician and White House domestic policy adviser, lacked the Senate support needed for confirmation. Axios first reported that the administration was dropping her nomination.

Questions from both parties

Overton, nominated in August, faced bipartisan questions about whether she would differ with President Donald Trump, including on his unsupported claims about childhood vaccines, the AP reported.

Sen. Bill Cassidy, the Republican physician who chairs the Senate health committee, said earlier Tuesday that he was undecided before a committee vote scheduled for Wednesday, according to the AP. The reports did not identify a replacement nominee.

Sources and visual credits

Reporting: Associated Press and Axios.

Visuals: Conceptual editorial illustration; not a photograph of the reported event.